Dengue Fever

Dengue is a viral infection transmitted by mosquitoes. It is widespread in many parts of the world and is becoming a problem across the globe. Dengue Fever can be a serious and life-threatening illness.

SwiftDX Protein Colour
Global problem

The Spread of Dengue Fever

Almost four billion people (40% of the world’s population) are at risk of contracting Dengue Fever. The number of Dengue Fever cases has increased over eight-fold over the last two decades, up to 5.2 million in 2019.

Previously contracted in developing countries, the disease is spreading to other parts of the world, now increasingly being found in both Europe and the United States. Transmission is caused by population growth, global warming and an increase in mosquito numbers in the affected regions. Dengue Fever is expected to spread further in developed countries in the coming years.

SwiftDX Protein Mole

Dengue Fever Rapid Detection

Need for Rapid Diagnostics

It is not possible to diagnose Dengue Fever early by symptoms alone. Severe Dengue Fever has a fatality rate of 20%, which drops to 1% if diagnosed and treated quickly

Current Rapid Diagnostics

Current LFAs are not sensitive enough to detect the disease, meaning hospitalisation and large blood samples are required. Furthermore, current diagnostics cannot access the vast majority of the available market, which is at the community level

Dengue Fever Market

The global Dengue Fever testing market is forecast at USD 600M by 2026

SwiftDx Solution

SwiftDx will produce a high-sensitivity, rapid Dengue Fever diagnostic test utilising accelerated approval pipelines for urgently required diagnostics.


Our affordable, easy to use and highly sensitive rapid LFA would allow rapid and simple community-level diagnosis of Dengue Fever, potentially saving hundreds of thousands of lives.